|
|
 |
|
Viewing report
|
|
|
|
Biotechnology Product Manufacturing
First Research, April 2012, Pages: 10
First Research is the leading industry intelligence company that helps sales teams perform faster and smarter, open doors, and close more deals. First Research performs the heavy lifting' by synthesizing hundreds of sources into an easy to digest format that a sales person can consume very quickly to better understand a prospect's business issues.'
Executive Summary
Brief Excerpt from Industry Overview Chapter:
The US biotechnology product manufacturing industry includes about 1,500 companies with combined annual revenue of more than $90 billion. Major companies include Amgen, Biogen Idec, Genentech (owned by Switzerland-based Roche), Genzyme, Life Technologies, and Monsanto. Because many drugs are now developed using biotechnology, the biotechnology and pharmaceutical industries overlap considerably. Related profiles include Biotechnology Research Services, Crop Production, and Pharmaceutical Manufacturing.
The global biotechnology industry includes about 7,000 companies with total revenues of $140 billion. Top regions for biotechnology include the US and Canada, Australia, and Europe, according to Ernst & Young’s Beyond Borders Global Biotechnology Report. Top companies include CSL Limited (Australia), Cangene (Canada), Galapagos nv (Belgium), and ADIMMUNE (Taiwan), as well as the biotech research arms of major international pharmaceutical companies including Novo Nordisk and Sanofi.
COMPETITIVE LANDSCAPE
Demand for biotechnology in the fields of medicine, agriculture, food, and science is driven by insurers' willingness to pay for new medical treatments, the global need to produce more food for a rapidly expanding population, and scientists' desire to find solutions for complex scientific and medical issues. Funding for biotech research is often provided by venture capital funds hoping to cash in on new products. The profitability of individual companies depends on the discovery and effective marketing of new products. Because the market for potential products is so large, small biotechnology companies can co-exist successfully with large ones if they have expertise in a particular line of research....
Product samples
A sample for this product is available. Please Login/Register to download this sample.
Customers who bought this item also bought
Fina Biotech - Product Pipeline Analysis
Sartorius Stedim Biotech S.A. (DIM) - Financial and Strategic SWOT Analysis Review
Viventia Biotechnologies Inc. - Product Pipeline Review - H2 2011
Pevion Biotech Ltd - Product Pipeline Review - Q1 2011
Teva Pharmaceutical Industries Limited - Product Pipeline Review - H2 2011
Marina Biotech, Inc. - Product Pipeline Review - H2 2011
Becton-Dickinson Medical Device Company Intelligence Report
Baxter International Medical Device Company Intelligence Report
Mycenax Biotech Inc. (4726) - Financial and Strategic SWOT Analysis Review
Marina Biotech, Inc. (MRNA) - Financial and Strategic SWOT Analysis Review
|
|
|
|
